|
|
||||||||
1 Departments of Molecular and Cellular Physiology, Louisiana State University Health Science Center, Shreveport, Louisiana 71130; and 2 Division of Child Development and Rehabilitation, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
We studied the effect of the
antihyperglycemic glitazones, ciglitazone, troglitazone, and
rosiglitazone, on glutamine metabolism in renal tubule-derived
Madin-Darby canine kidney (MDCK) cells. Troglitazone (25 µM) enhanced
glucose uptake and lactate production by 108 and 92% (both
P < 0.001). Glutamine utilization was not inhibited,
but alanine formation decreased and ammonium formation increased (both
P < 0.005). The decrease in net alanine formation occurred with a change in alanine aminotransferase (ALT)
reactants, from close to equilibrium to away from equilibrium,
consistent with inhibition of ALT activity. A shift of glutamine's
amino nitrogen from alanine into ammonium was confirmed by using
L-[2-15N]glutamine and measuring the
[15N]alanine and [15N]ammonium production.
The glitazone-induced shift from alanine to ammonium in glutamate
metabolism was dose dependent, with troglitazone being twofold more
potent than rosiglitazone and ciglitazone. All three glitazones induced
a spontaneous cellular acidosis, reflecting impaired acid extrusion in
responding to both an exogenous (NH
rosiglitazone; troglitazone; ciglitazone; L-[2-15N]glutamine; 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein; glutamate; alanine; ammonium; Madin-Darby canine kidney cells; intracellular pH
This article has been cited by other articles:
![]() |
F. Turturro, R. Oliver III, E. Friday, I. Nissim, and T. Welbourne Troglitazone and pioglitazone interactions via PPAR-{gamma}-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1137 - C1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Oliver III, E. Friday, F. Turturro, A. Lacy, and T. Welbourne Troglitazone's rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiological responses Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1257 - F1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nie, S. Sweetser, M. Rinella, and R. M. Green Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-{alpha} and -{gamma} Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G207 - G212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Welbourne, E. Friday, R. Fowler, F. Turturro, and I. Nissim Troglitazone acts by PPAR{gamma} and PPAR{gamma}-independent pathways on LLC-PK1-F+ acid-base metabolism Am J Physiol Renal Physiol, January 1, 2004; 286(1): F100 - F110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |